MGMT promoter methylation status in anaplastic meningiomas.
Brokinkel
Benjamin
B
Fischer
Bernhard R
BR
Peetz-Dienhart
Susanne
S
Ebel
Heinrich
H
Sepehrnia
Abolghassem
A
Rama
Burckhard
B
Albert
Friedrich K
FK
Stummer
Walter
W
Paulus
Werner
W
Hasselblatt
Martin
M
D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology / Q000627:therapeutic use; D019175:DNA Methylation / Q000187:drug effects; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000378:metabolism*; D008579:Meningioma / Q000188:drug therapy / Q000378:metabolism*; D008875:Middle Aged; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000378:metabolism*
D018906:Antineoplastic Agents, Alkylating; D019853:O(6)-Methylguanine-DNA Methyltransferase
Cancer Res. 2008 Jul 15;68(14):5706-15
18632623
Cancer Genet Cytogenet. 2008 Nov;187(1):25-7
18992637
Neurology. 2004 Apr 13;62(7):1210-2
15079029
J Neurooncol. 2009 Jan;91(2):151-5
18795231
Neurosurgery. 2005 Sep;57(3):538-50; discussion 538-50
16145534
Acta Neuropathol. 2004 Nov;108(5):413-21
15365725
J Clin Oncol. 2007 Sep 10;25(26):4127-36
17827463
Nat Rev Neurol. 2010 Jan;6(1):39-51
19997073